<DOC>
	<DOC>NCT01749098</DOC>
	<brief_summary>To assess if PF-04958242 can attenuate the ketamine-induced cognitive impairment in verbal learning and memory, episodic memory and spatial working memory in healthy volunteers.</brief_summary>
	<brief_title>A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy male subjects 21 45 years old. Able to read and write English as primary language. Subjects who are willing to comply with study procedures. History of any substance abuse or dependence disorder meeting DSMIV criteria and/or by SCIDNP within the past 12 months, with the exception of nicotine. Known sensitivity to ketamine Any history of DSMIV Axis I psychiatric disorders, determined by SCIDNP interview or diagnoses in the view of the investigator.</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>PF-04958242</keyword>
	<keyword>ketamine</keyword>
	<keyword>cognition</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>